More on UNCY

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-820.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (3/27/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Unicycive Therapeutics, Inc (NQ:UNCY)
Delayed: 6.59 -0.24 (3.51%)
Prev. Close $6.83  
Open$6.72 
52 Wk High$ 
52 Wk Low$ 
Day High$6.85 
Day Low$6.48 
P/E N/A  
EPS$ 
Volume691,015 

Friends, Peers and Foes (?): HUM, APLT, VSTS, FIVE, LNTH (more...)

Mar 5, 2026 09:15 AM Important Notice to Long-Term Shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT); Kyndryl Holdings (NYSE: KD); Molina Healthcare, Inc. (NYSE: MOH); and Unicycive Therapeutics, Inc. (NASDAQ: UN
Feb 19, 2026 07:43 AM WestPark Capital Starts Unicycive Therapeutics (UNCY) at Buy
Feb 17, 2026 04:46 PM Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Feb 17, 2026 09:16 AM Important Notice to Long-Term Shareholders of Unicycive Therapeutics, Inc. (UNCY): Grabar Law Office Is Investigating Claims on Your Behalf
Feb 13, 2026 05:08 PM Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Nantahala Capital Management, LLC
Feb 10, 2026 01:15 PM Form SCHEDULE 13G/A Unicycive Therapeutics, Filed by: Octagon Capital Advisors LP
Feb 4, 2026 07:05 AM Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit
Jan 29, 2026 09:15 AM UPDATE - Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
Jan 29, 2026 07:05 AM FDA accepts Unicycive drug application resubmission with June review date
Jan 29, 2026 07:05 AM Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
View All Articles

Entities mentioned with UNCY

View All Entities